Privia Health Group Inc (PRVA)
Return on equity (ROE)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 23,079 | 38,017 | 33,998 | 16,249 | -8,585 | -38,340 | -49,079 | -211,138 | -188,230 | |||
| Total stockholders’ equity | US$ in thousands | 561,437 | 544,681 | 525,232 | 513,276 | 499,094 | 470,186 | 445,155 | 435,042 | 426,872 | 410,600 | 393,300 | 152,247 |
| ROE | 4.11% | 6.98% | 6.47% | 3.17% | -1.72% | -8.15% | -11.03% | -48.53% | -44.10% |
December 31, 2023 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $23,079K ÷ $561,437K
= 4.11%
Privia Health Group Inc's return on equity (ROE) has shown a positive trend over the past two quarters, with a notable improvement from Q1 2023 to Q3 2023. The recent ROE figures of 4.11% in Q4 2023 and 6.98% in Q3 2023 indicate that the company has been able to generate a respectable level of profit relative to its shareholders' equity. However, it is important to note that the ROE was negative in the previous four quarters, indicating challenges in generating returns for shareholders during that period.
The significant improvement in ROE from negative figures in the previous quarters to positive figures in the latest quarters suggests that Privia Health Group Inc may have implemented effective strategies to enhance profitability and efficiency in its operations. Continued monitoring and analysis of the company's financial performance will be necessary to assess the sustainability of this positive trend in ROE and to identify any potential risks or challenges that may impact shareholder value in the future.
Peer comparison
Dec 31, 2023